120 related articles for article (PubMed ID: 29721733)
21. Lifetime Economic Burden of Crohn's Disease and Ulcerative Colitis by Age at Diagnosis.
Lichtenstein GR; Shahabi A; Seabury SA; Lakdawalla DN; Espinosa OD; Green S; Brauer M; Baldassano RN
Clin Gastroenterol Hepatol; 2020 Apr; 18(4):889-897.e10. PubMed ID: 31326606
[TBL] [Abstract][Full Text] [Related]
22. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of tacrolimus in refractory ulcerative colitis and Crohn's disease: a single-center experience.
Benson A; Barrett T; Sparberg M; Buchman AL
Inflamm Bowel Dis; 2008 Jan; 14(1):7-12. PubMed ID: 17879277
[TBL] [Abstract][Full Text] [Related]
24. Predictors of health-related quality of life and adherence in Crohn's disease and ulcerative colitis: implications for clinical management.
Tabibian A; Tabibian JH; Beckman LJ; Raffals LL; Papadakis KA; Kane SV
Dig Dis Sci; 2015 May; 60(5):1366-74. PubMed ID: 25559754
[TBL] [Abstract][Full Text] [Related]
25. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
[TBL] [Abstract][Full Text] [Related]
26. Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease.
Vavricka SR; Spigaglia SM; Rogler G; Pittet V; Michetti P; Felley C; Mottet C; Braegger CP; Rogler D; Straumann A; Bauerfeind P; Fried M; Schoepfer AM;
Inflamm Bowel Dis; 2012 Mar; 18(3):496-505. PubMed ID: 21509908
[TBL] [Abstract][Full Text] [Related]
27. Different Profile of Efficacy of Thiopurines in Ulcerative Colitis and Crohn's Disease.
Rispo A; Testa A; De Palma GD; Donetto S; Diaferia M; Musto D; Nardone O; Maione F; Caporaso N; Castiglione F
Inflamm Bowel Dis; 2015 Nov; 21(11):2570-5. PubMed ID: 26222340
[TBL] [Abstract][Full Text] [Related]
28. Analysis of TNF-antagonist switch over time and associated risk factors in the Swiss Inflammatory Bowel Disease Cohort.
Hiroz P; Vavricka SR; Fournier N; Safroneeva E; Pittet V; Rogler G; Schoepfer AM;
Scand J Gastroenterol; 2014 Oct; 49(10):1207-18. PubMed ID: 25120029
[TBL] [Abstract][Full Text] [Related]
29. [p-ANCA and ASCA antibodies in the differential diagnosis between ulcerative rectocolitis and Crohn's disease].
Lecis P; Germanà B; Papa N; Bertiato G; Doglioni C; Galliani E; Biedo FC
Recenti Prog Med; 2002 May; 93(5):308-13. PubMed ID: 12050913
[TBL] [Abstract][Full Text] [Related]
30. Endoscopic ultrasound of the colon for the differentiation of Crohn's disease and ulcerative colitis in comparison with healthy controls.
Ellrichmann M; Wietzke-Braun P; Dhar S; Nikolaus S; Arlt A; Bethge J; Kuehbacher T; Wintermeyer L; Balschun K; Klapper W; Schreiber S; Fritscher-Ravens A
Aliment Pharmacol Ther; 2014 Apr; 39(8):823-33. PubMed ID: 24612000
[TBL] [Abstract][Full Text] [Related]
31. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
[TBL] [Abstract][Full Text] [Related]
32. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
[TBL] [Abstract][Full Text] [Related]
33. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.
Ardizzone S; Bollani S; Bettica P; Bevilacqua M; Molteni P; Bianchi Porro G
J Intern Med; 2000 Jan; 247(1):63-70. PubMed ID: 10672132
[TBL] [Abstract][Full Text] [Related]
34. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease.
Costa F; Mumolo MG; Ceccarelli L; Bellini M; Romano MR; Sterpi C; Ricchiuti A; Marchi S; Bottai M
Gut; 2005 Mar; 54(3):364-8. PubMed ID: 15710984
[TBL] [Abstract][Full Text] [Related]
35. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
[TBL] [Abstract][Full Text] [Related]
36. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
[TBL] [Abstract][Full Text] [Related]
38. Differing Relationship of Psycho-Social Variables with Active Ulcerative Colitis or Crohn's Disease.
Sarid O; Slonim-Nevo V; Schwartz D; Friger M; Sergienko R; Pereg A; Vardi H; Chernin E; Singer T; Greenberg D; Odes S;
Int J Behav Med; 2018 Jun; 25(3):341-350. PubMed ID: 29524119
[TBL] [Abstract][Full Text] [Related]
39. Microscopic colitis in patients with ulcerative colitis or Crohn's disease: a retrospective observational study and review of the literature.
Wickbom A; Bohr J; Nyhlin N; Eriksson A; Lapidus A; Münch A; Ung KA; Vigren L; Öst Å; Tysk C;
Scand J Gastroenterol; 2018 Apr; 53(4):410-416. PubMed ID: 29546806
[TBL] [Abstract][Full Text] [Related]
40. Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis.
Colombel JF; Sandborn WJ; Reinisch W; Peyrin-Biroulet L; Panaccione R; Rutgeerts P; Hanauer SB; Ghosh S; Van Assche G; Robinson AM; Lau W; Maa JF; Huang B; Pappalardo B; Read H
Aliment Pharmacol Ther; 2018 Jan; 47(2):219-228. PubMed ID: 29159817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
